Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net income	$ (49,000,000.0)	$ 27,000,000.0
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of property, plant and equipment and amortization of intangible assets and right of use assets	97,200,000	90,000,000.0
Goodwill impairment	80,800,000	0
Amortization of debt issuance costs	1,200,000	1,100,000
Share-based compensation	10,000,000.0	11,300,000
Deferred taxes	(27,100,000)	(12,000,000.0)
Foreign currency transactions	(9,800,000)	(7,400,000)
Changes in operating assets and liabilities, net:
Trade receivables	(32,900,000)	(26,200,000)
Inventories	34,300,000	(17,600,000)
Trade payables	3,900,000	(8,200,000)
Other provisions	(3,500,000)	2,600,000
Income tax liabilities	8,800,000	(29,500,000)
Other assets and liabilities, net	9,000,000.0	(300,000)
Net cash provided by operating activities	122,900,000	30,800,000
Cash flows from investing activities:
Acquisition of property, plant and equipment	(112,300,000)	(135,700,000)
Net cash used in investing activities	(112,300,000)	(135,700,000)
Cash flows from financing activities:
Repayments of long-term debt	(5,200,000)	(2,800,000)
Payments for debt issue costs	(3,500,000)	(200,000)
Cash inflows related to current financial liabilities	122,600,000	242,100,000
Cash outflows related to current financial liabilities	(91,100,000)	(98,300,000)
Dividends paid	(3,500,000)	(3,600,000)
Repurchase of Common stock	(24,800,000)	(17,900,000)
Net cash provided by (used in) financing activities	(5,500,000)	119,300,000
Increase in cash, cash equivalents and restricted cash	5,100,000	14,400,000
Cash, cash equivalents and restricted cash at the beginning of the period	44,700,000	40,200,000
Effect of exchange rate changes on cash	3,000,000.0	100,000
Cash, cash equivalents and restricted cash at the end of the period	52,800,000	54,700,000
Less restricted cash at the end of the period	1,500,000	1,500,000
Cash and cash equivalents at the end of the period	$ 51,300,000	$ 53,200,000